Min Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Min Hu has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
Li Tan
Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; Molecular Diagnostic Technology Hunan Engineering Research Center, Changsha, China; Clinical Medical Research Center for Molecular Diagnosis of Infectious Diseases in Hunan Province, Changsha, China; Center for Clinical Molecular Diagnostics in Hunan Province, Changsha, China
11 shared publicationsZhiyang Chen
Department of Clinical Laboratory, the Second Xiangya Hospital of Central South University, Changsha, China; Molecular Diagnostic Technology Hunan Engineering Research Center, China; Clinical Medical Research Center for Molecular Diagnosis of infectious diseases in Hunan Province, China
11 shared publicationsZiyang Li
Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Center for Clinical Molecular Diagnostics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
8 shared publicationsBingchu Li
Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Center for Clinical Molecular Diagnostics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
7 shared publications- Qichen Long
Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, China
7 shared publications Xing Lyu
Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Center for Clinical Molecular Diagnostics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
7 shared publications
Latest Publications
- 1 October 2026
- Published by Elsevier in Clinica Chimica Acta
- Vol. 594, 122869
A rapid sequential salting-out/isoelectric precipitation LC-MS/MS method for quantifying cytokeratin 18 in human ascitic fluid
- 1 October 2026
- Published by Elsevier in Clinica Chimica Acta
- Vol. 594, 122869
A rapid sequential salting-out/isoelectric precipitation LC-MS/MS method for quantifying cytokeratin 18 in human ascitic fluid
- Open Access
- 29 April 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
A novel serum metabolite classifier for identifying Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) integrating metabolomics and machine learning
Metabolic dysfunction-associated steatotic liver disease (MASLD) presents a growing global health burden, while reliable non-invasive biomarkers for identi
- 29 April 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Open AccessA novel serum metabolite classifier for identifying Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) integrating metabolomics and machine learning
Metabolic dysfunction-associated steatotic liver disease (MASLD) presents a growing global health burden, while reliable non-invasive biomarkers for identi
- 9 April 2026
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 45 (8) , 2235-2247
Metagenomic next-generation sequencing for comprehensive pathogen detection in intraocular infection
- 9 April 2026
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 45 (8) , 2235-2247
Metagenomic next-generation sequencing for comprehensive pathogen detection in intraocular infection
- 11 March 2026
- Published by Elsevier in Clinica Chimica Acta
- Vol. 587, 120971
Targeted next-generation sequencing in diagnosing reproductive tract infections: a comparative study
- 11 March 2026
- Published by Elsevier in Clinica Chimica Acta
- Vol. 587, 120971
Targeted next-generation sequencing in diagnosing reproductive tract infections: a comparative study
- Open Access
- 1 March 2026
- Vol. 44 (3) , 267-275
3种液相色谱-串联质谱法检测脂溶性维生素的性能确认和一致性评价
精准测定脂溶性维生素A、D、E、K(VA、25(OH)D、VE、VK)水平对健康评估与疾病诊断具有重要价值,液相色谱-串联质谱法(LC-MS/MS)因其高特异性与灵敏度成为其主要检测手段,但方法间结果的可比性与一致性仍待提升。本研究依据CLSI C62及《液相色谱-质谱临床应用建议》,对3种LC-MS/MS方法检测脂溶性维生素的线性范围、检出限、定量限、精密度和准确度等进行系统评估。研究选取中南大学湘雅二医院于2022年8月至10月期间留存的40例剩余血清样本,采用3种LC-MS/MS方法进行脂溶性维生素检测。通过Passing-Bablok回归分析评估3种方法之间的相关性,绘制Bland-Altman图分析其相对偏差,并以一致性相关系数(CCC)评价3种方法检测结果的一致性。同时,比较不同方法在重新校准前后的检测一致性。研究结果显示,3种LC-MS/MS方法的总变异系数(CV)为2.7%~10.1%,加标回收率为88.8%~109.2%,表明其检测性能符合临床应用要求。一致性分析结果显示,其中两种方法在25(OH)D检测中表现出中等一致性(CCC=0.938),其余LC-MS/MS方法的一致性相关系数范围为0.322~0.853,存在一定差异。经统一校准品重新校准后,除VK外,其余脂溶性维生素的检测一致性明显改善,CCC提高至0.918~0.983。综上所述,3种LC-MS/MS方法在检测脂溶性维生素方面具备良好的性能,但方法间一致性尚存不足。通过使用统一校准品进行重新校准,可显著提升检测结果的一致性。本研究为分析脂溶性维生素临床质谱检测方法的一致化现状及其优化路径提供了数据支持,有助于提高检测结果的准确性与可靠性,从而为临床诊断与治疗提供更坚实的依据。
- 1 March 2026
- Vol. 44 (3) , 267-275
Open Access3种液相色谱-串联质谱法检测脂溶性维生素的性能确认和一致性评价
精准测定脂溶性维生素A、D、E、K(VA、25(OH)D、VE、VK)水平对健康评估与疾病诊断具有重要价值,液相色谱-串联质谱法(LC-MS/MS)因其高特异性与灵敏度成为其主要检测手段,但方法间结果的可比性与一致性仍待提升。本研究依据CLSI C62及《液相色谱-质谱临床应用建议》,对3种LC-MS/MS方法检测脂溶性维生素的线性范围、检出限、定量限、精密度和准确度等进行系统评估。研究选取中南大学湘雅二医院于2022年8月至10月期间留存的40例剩余血清样本,采用3种LC-MS/MS方法进行脂溶性维生素检测。通过Passing-Bablok回归分析评估3种方法之间的相关性,绘制Bland-Altman图分析其相对偏差,并以一致性相关系数(CCC)评价3种方法检测结果的一致性。同时,比较不同方法在重新校准前后的检测一致性。研究结果显示,3种LC-MS/MS方法的总变异系数(CV)为2.7%~10.1%,加标回收率为88.8%~109.2%,表明其检测性能符合临床应用要求。一致性分析结果显示,其中两种方法在25(OH)D检测中表现出中等一致性(CCC=0.938),其余LC-MS/MS方法的一致性相关系数范围为0.322~0.853,存在一定差异。经统一校准品重新校准后,除VK外,其余脂溶性维生素的检测一致性明显改善,CCC提高至0.918~0.983。综上所述,3种LC-MS/MS方法在检测脂溶性维生素方面具备良好的性能,但方法间一致性尚存不足。通过使用统一校准品进行重新校准,可显著提升检测结果的一致性。本研究为分析脂溶性维生素临床质谱检测方法的一致化现状及其优化路径提供了数据支持,有助于提高检测结果的准确性与可靠性,从而为临床诊断与治疗提供更坚实的依据。
- Open Access
- 29 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Plasma catecholamine metabolites are associated with disease activity and pathophysiological features in systemic lupus erythematosus using targeted LC–MS/MS
Systemic lupus erythematosus (SLE) presents diagnostic and disease monitoring challenges due to its heterogeneity and variable activity. In this cross-sectional study, we investigated the association of plasma catecholamine (CA) metabolites with SLE status and disease activity. Plasma samples from 88 SLE patients and 64 healthy controls were analyzed using targeted liquid chromatography-tandem mass spectrometry to quantify dopamine (DA), epinephrine (E), norepinephrine (NE), 3-methoxytyramine (3MT), metanephrine (MN), and normetanephrine (NMN). Significant alterations in CA metabolites levels were observed in SLE patients compared to controls, independent of glucocorticoid treatment. Orthogonal partial least squares-discriminant analysis (OPLS-DA) suggested distinct metabolic profiles in active SLE. NE, NMN, MN, and E showed notable group differences and correlations with inflammatory markers, clinical features, complement levels, and SLE Disease Activity Index (SLEDAI) scores. Receiver operating characteristic analysis demonstrated strong diagnostic performance for individual CA biomarkers, while combined plasma CA metabolites assessment yielded superior predictive capability for SLE activity (AUC: 0.866, 95% CI: 0.785–0.947). These findings highlight the potential of plasma CA metabolites, particularly NE and NMN, are associated with SLE disease activity and may serve as potential associative biomarkers. Further validation in independent and longitudinal cohorts is warranted.
- 29 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessPlasma catecholamine metabolites are associated with disease activity and pathophysiological features in systemic lupus erythematosus using targeted LC–MS/MS
Systemic lupus erythematosus (SLE) presents diagnostic and disease monitoring challenges due to its heterogeneity and variable activity. In this cross-sectional study, we investigated the association of plasma catecholamine (CA) metabolites with SLE status and disease activity. Plasma samples from 88 SLE patients and 64 healthy controls were analyzed using targeted liquid chromatography-tandem mass spectrometry to quantify dopamine (DA), epinephrine (E), norepinephrine (NE), 3-methoxytyramine (3MT), metanephrine (MN), and normetanephrine (NMN). Significant alterations in CA metabolites levels were observed in SLE patients compared to controls, independent of glucocorticoid treatment. Orthogonal partial least squares-discriminant analysis (OPLS-DA) suggested distinct metabolic profiles in active SLE. NE, NMN, MN, and E showed notable group differences and correlations with inflammatory markers, clinical features, complement levels, and SLE Disease Activity Index (SLEDAI) scores. Receiver operating characteristic analysis demonstrated strong diagnostic performance for individual CA biomarkers, while combined plasma CA metabolites assessment yielded superior predictive capability for SLE activity (AUC: 0.866, 95% CI: 0.785–0.947). These findings highlight the potential of plasma CA metabolites, particularly NE and NMN, are associated with SLE disease activity and may serve as potential associative biomarkers. Further validation in independent and longitudinal cohorts is warranted.
- 28 December 2025
- Vol. 50 (12) , 2335-2345
[Diagnostic value of combined application of semaphorin 7A, calponin 1 and D-dimer in acute aortic dissection].
Acute aortic dissection (AAD) is a life-threatening condition with difficulty in early differential diagnosis, and ideal biomarkers are still lacking. This study aims to investigate the diagnostic value of serum semaphorin 7A (Sema7A), calponin 1 (CNN1), and plasma D-dimer, alone and in combination, in patients with AAD. A retrospective study was conducted. 90 patients with AAD who visited the Second Xiangya Hospital of Central South University from December 2022 to December 2023 were enrolled, along with 53 patients with acute myocardial infarction (AMI) and 18 patients with acute pulmonary embolism (APE). Additionally, 25 patients without chest pain symptoms or cardiogenic diseases admitted during the same period were included as the control group. General clinical data and laboratory indicators were collected. Serum Sema7A and CNN1 levels were detected using enzyme-linked immunosorbent assay or chemiluminescence immunoassay. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for AAD. Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic value of D-dimer, Sema7A, and CNN1. Serum Sema7A and CNN1 levels in the AAD group were significantly higher than those in the control, AMI, and APE groups (all PP0.05). Binary logistic regression analysis showed that elevated levels of Sema7A (OR=2.138, POR=1.211, P=0.002), and CNN1 (OR=1.042, P=0.016) were independent risk factors for AAD. ROC curve analysis demonstrated that the areas under the curve (AUC) for Sema7A, CNN1, and D-dimer for distinguishing AAD from non-AAD patients were 0.870, 0.726, and 0.836, respectively (all PPPP<0.05). The combined application of Sema7A, CNN1, and D-dimer significantly improves the diagnostic performance for AAD and may also serve as an indicative marker for clinical classification, providing new insights for the early differential diagnosis of AAD.
- 28 December 2025
- Vol. 50 (12) , 2335-2345
[Diagnostic value of combined application of semaphorin 7A, calponin 1 and D-dimer in acute aortic dissection].
Acute aortic dissection (AAD) is a life-threatening condition with difficulty in early differential diagnosis, and ideal biomarkers are still lacking. This study aims to investigate the diagnostic value of serum semaphorin 7A (Sema7A), calponin 1 (CNN1), and plasma D-dimer, alone and in combination, in patients with AAD. A retrospective study was conducted. 90 patients with AAD who visited the Second Xiangya Hospital of Central South University from December 2022 to December 2023 were enrolled, along with 53 patients with acute myocardial infarction (AMI) and 18 patients with acute pulmonary embolism (APE). Additionally, 25 patients without chest pain symptoms or cardiogenic diseases admitted during the same period were included as the control group. General clinical data and laboratory indicators were collected. Serum Sema7A and CNN1 levels were detected using enzyme-linked immunosorbent assay or chemiluminescence immunoassay. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for AAD. Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic value of D-dimer, Sema7A, and CNN1. Serum Sema7A and CNN1 levels in the AAD group were significantly higher than those in the control, AMI, and APE groups (all PP0.05). Binary logistic regression analysis showed that elevated levels of Sema7A (OR=2.138, POR=1.211, P=0.002), and CNN1 (OR=1.042, P=0.016) were independent risk factors for AAD. ROC curve analysis demonstrated that the areas under the curve (AUC) for Sema7A, CNN1, and D-dimer for distinguishing AAD from non-AAD patients were 0.870, 0.726, and 0.836, respectively (all PPPP<0.05). The combined application of Sema7A, CNN1, and D-dimer significantly improves the diagnostic performance for AAD and may also serve as an indicative marker for clinical classification, providing new insights for the early differential diagnosis of AAD.
- Open Access
- 10 October 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-8
Toxoplasma gondii infection diagnosed by tNGS in a patient with acute lymphoblastic leukemia: a case report
Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan parasite. In the context of hematological malignancies, the immunosuppression induced by chemotherapy and the underlying disease state render patients highly vulnerable to T. gondii reactivation. The consequences of such infections can be extremely severe, often leading to life-threatening complications such as toxoplasmic encephalitis (TE). There are few reports on the detection of T. gondii infection in cerebrospinal fluid (CSF) by targeted next-generation sequencing (tNGS). A 5-year-old girl diagnosed with ALL developed an unexplained fever and cough during the course of chemotherapy. Initial routine laboratory tests failed to identify the causative pathogen. Due to the persistence of symptoms and the patient’s immunocompromised state, further investigations were pursued. tNGS of blood and CSF unexpectedly revealed T. gondii sequences. Brain MRI demonstrated abnormal signals, including ring-line high signal, which are characteristic of TE. Based on these findings, a definitive diagnosis of TE was established. The patient was promptly initiated on a combination therapy of trimethoprim-sulfamethoxazole (SMZ-TMP) and clindamycin, and the patient responded well to the treatment and subsequently discharged in stable condition and continued on maintenance therapy to prevent relapse. This case highlights the timely use of tNGS, a new tool with fast speed, high accuracy, and cost-effectiveness that can help identify atypical infections and start early therapy. Moreover, tNGS has great potential in various other clinical scenarios. In critically ill patients with complex infections where time is of the essence, tNGS can provide a comprehensive pathogen profile in a short time.
- 10 October 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-8
Open AccessToxoplasma gondii infection diagnosed by tNGS in a patient with acute lymphoblastic leukemia: a case report
Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan parasite. In the context of hematological malignancies, the immunosuppression induced by chemotherapy and the underlying disease state render patients highly vulnerable to T. gondii reactivation. The consequences of such infections can be extremely severe, often leading to life-threatening complications such as toxoplasmic encephalitis (TE). There are few reports on the detection of T. gondii infection in cerebrospinal fluid (CSF) by targeted next-generation sequencing (tNGS). A 5-year-old girl diagnosed with ALL developed an unexplained fever and cough during the course of chemotherapy. Initial routine laboratory tests failed to identify the causative pathogen. Due to the persistence of symptoms and the patient’s immunocompromised state, further investigations were pursued. tNGS of blood and CSF unexpectedly revealed T. gondii sequences. Brain MRI demonstrated abnormal signals, including ring-line high signal, which are characteristic of TE. Based on these findings, a definitive diagnosis of TE was established. The patient was promptly initiated on a combination therapy of trimethoprim-sulfamethoxazole (SMZ-TMP) and clindamycin, and the patient responded well to the treatment and subsequently discharged in stable condition and continued on maintenance therapy to prevent relapse. This case highlights the timely use of tNGS, a new tool with fast speed, high accuracy, and cost-effectiveness that can help identify atypical infections and start early therapy. Moreover, tNGS has great potential in various other clinical scenarios. In critically ill patients with complex infections where time is of the essence, tNGS can provide a comprehensive pathogen profile in a short time.